Nicolas Marx

Nicolas Marx

Auto-generated profile, based on publicly available information

Nicolas Marx

Universität für Bodenkultur Wien

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Biotechnology Journal
Verified
Journal Article
Open access
PDF file
NMNicolas Marx
Nicolas Marx
CGClemens Grünwald‐Gruber
Clemens Grünwald‐Gruber
NBNina Bydlinski
Nina Bydlinski
HDHeena Dhiman
Heena Dhiman
LNLy Ngoc Nguyen
Ly Ngoc Nguyen
NBNicole Borth
Nicole Borth
Despite great efforts to control and modify gene expression of Chinese Hamster Ovary (CHO) cells by conventional genetic engineering approaches, i.e. overexpression or knockdown/‐out, subclonal variation, induced unknown regulatory effects as well as overexpression stress are still a major hurdle for efficient cell line engineering and for unequivocal characterization of gene function. The use of epigenetic modulators – key players in CHO clonal heterogeneity – has only been marginally addressed so far. Here, we present the application of an alternative engineering strategy in CHO cells by utilizing targeted epigenetic editing tools that enable the turning‐on or ‐off of genes without altering the genomic sequence. The present, but silent beta‐galactoside alpha‐2,6‐sialyltransferase 1 (ST6GAL1) gene is activated by targeting the catalytic domain (CD) of Ten‐Eleven Translocation methylcytosine dioxygenase 1 (TET1) via deactivated Cas9 (dCas9) to its methylated promoter. Stable upregulation in up to 60% of transfected cells is achieved over a time span of more than 80 days. No difference in growth and recombinant protein productivity is observed between activated and control cultures. Re‐silencing by targeted methylation via DNA methyltransferase (DNMT) 3A‐CD resulted in an up to 5.4‐fold reduction of ST6GAL1 mRNA expression in ST6GAL1 expressing cells. This proof‐of‐concept demonstrates the feasibility of using epigenetic editing tools to efficiently modulate gene expression and provide a promising complement to conventional genetic engineering in CHO cells.

4 July 2019 in Biotechnology Journal
Verified
Journal Article
Open access
PDF file
LNLy Ngoc Nguyen
Ly Ngoc Nguyen
MBMartina Baumann
Martina Baumann
HDHeena Dhiman
Heena Dhiman
NMNicolas Marx
Nicolas Marx
VSValerie Schmieder
Valerie Schmieder
NBNicole Borth
Nicole Borth
For the industrial production of recombinant proteins in mammalian cell lines, a high rate of gene expression is desired. Therefore, strong viral promoters are commonly used. However, these have several drawbacks as they override cellular responses, are not integrated into the cellular network, and thus can induce stress and potentially epigenetic silencing. Endogenous promoters potentially have the advantage of a better response to cellular state and thus a lower stress level by uncontrolled overexpression of the transgene. Such fine‐tuning is typically achieved by endogenous enhancers and other regulatory elements, which are difficult to identify purely based on the genomic sequence. Here, Chinese hamster ovary (CHO) endogenous promoters and enhancers are identified using histone marks and chromatin states, ranked based on expression level and tested for normalized promoter strength. Successive truncation of these promoters at the 5′‐ and 3′‐end as well as the combination with enhancers are identified in the vicinity of the promoter sequence further enhance promoter activity up to threefold. In an initial screen within stable cell lines, the strongest CHO promoter appears to be more stable than the human cytomegalovirus promoter with enhancer, making it a promising candidate for recombinant protein production and cell engineering applications. A deeper understanding of promoter functionality and response elements will be required to take full advantage of such promoters for cell engineering, in particular, for multigene network engineering applications.

30 November 2023 in New Biotechnology
Verified
Journal Article
Open access
PEPeter Eisenhut
Peter Eisenhut
NMNicolas Marx
Nicolas Marx
GBGiulia Borsi
Giulia Borsi
MPMaja Papež
Maja Papež
CRCaterina Ruggeri
Caterina Ruggeri
NBNicole Borth
Nicole Borth
Cells, both of prokaryotic and eukaryotic origin, have developed dedicated molecular mechanisms to tightly control expression levels of their genes where the specific transcriptomic signature across all genes eventually determines the cell phenotype. Modulating cellular phenotypes is of major interest, either to study their role in disease or to reprogram cells for the manufacture of recombinant products, such as biopharmaceuticals. For the latter, cells of mammalian origin, such as Chinese hamster ovary (CHO) and Human embryonic kidney 293 (HEK293) cells, are most commonly employed to produce therapeutic proteins. Altering their phenotype is often achieved randomly by subcloning and selection of appropriate behavior or by genetic engineering. In both cases, the objective is to obtain expression systems that generate the desired product with the highest possible quality and quantity. Early genetic engineering approaches have often been attempted by "uncontrolled" overexpression or knock-down/-out of specific genetic factors. Many studies in the past years, however, have highlighted that a controlled manipulation of transgene expression, by rationally regulating and fine-tuning the strength of overexpression or knock-down to an optimum level, can adjust phenotypic traits with much greater precision than such "uncontrolled" approaches. To control and (fine-)tune the expression level of one or multiple transgenes or endogenous genes, synthetic biology tools inspired by naturally occurring gene regulation mechanisms have been generated to develop novel, molecular toolboxes that enable (fine-)tunable and/or inducible control of gene expression. In this review, we discuss various molecular tools that have been established in mammalian cell lines and group them by their mode of action: transcriptional, post-transcriptional, translational and post-translational regulation. Major emphasis is placed on studies in which such tools were employed to engineer recombinant protein production in CHO or other mammalian cell factories. We discuss the advantages and disadvantages of using these tools for each cell regulatory layer and with respect to cell line engineering approaches. This review highlights the existence of a plethora of synthetic toolboxes that could be employed, alone or in combination, to optimize cellular systems and eventually gain enhanced control over the cellular phenotype to equip mammalian cell factories with the tools required for efficient production of emerging, more difficult-to-express biologics formats.

14 July 2020 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
PDF file
MWMarcus Weinguny
Marcus Weinguny
PEPeter Eisenhut
Peter Eisenhut
GKGerald Klanert
Gerald Klanert
NVNikolaus Virgolini
Nikolaus Virgolini
NMNicolas Marx
Nicolas Marx
NBNicole Borth
Nicole Borth
Chinese hamster ovary (CHO) cells produce a large share of today's biopharmaceuticals. Still, the generation of satisfactory producer cell lines is a tedious undertaking. Recently, it was found that CHO cells, when exposed to new environmental conditions, modify their epigenome, suggesting that cells adapt their gene expression pattern to handle new challenges. The major aim of the present study was to employ artificially induced, random changes in the DNA‐methylation pattern of CHO cells to diversify cell populations and consequently increase the finding of cell lines with improved cellular characteristics. To achieve this, DNA methyltransferases and/or the ten‐eleven translocation enzymes were downregulated by RNA interference over a time span of ∼16 days. Methylation analysis of the resulting cell pools revealed that the knockdown of DNA methyltransferases was highly effective in randomly demethylating the genome. The same approach, when applied to stable CHO producer cells resulted in (a) an increased productivity diversity in the cell population, and (b) a higher number of outliers within the population, which resulted in higher specific productivity and titer in the sorted cells. These findings suggest that epigenetics play a previously underestimated, but actually important role in defining the overall cellular behavior of production clones.

14 April 2023 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
KLKlaus Leitner
Klaus Leitner
KMKrishna Motheramgari
Krishna Motheramgari
NBNicole Borth
Nicole Borth
NMNicolas Marx
Nicolas Marx
The integration of a transgene expression construct into the host genome is the initial step for the generation of recombinant cell lines used for biopharmaceutical production. The stability and level of recombinant gene expression in Chinese hamster ovary (CHO) can be correlated to the copy number, its integration site as well as the epigenetic context of the transgene vector. Also, undesired integration events, such as concatemers, truncated, and inverted vector repeats, are impacting the stability of recombinant cell lines. Thus, to characterize cell clones and to isolate the most promising candidates, it is crucial to obtain information on the site of integration, the structure of integrated sequence and the epigenetic status. Current sequencing techniques allow to gather this information separately but do not offer a comprehensive and simultaneous resolution. In this study, we present a fast and robust nanopore Cas9‐targeted sequencing (nCats) pipeline to identify integration sites, the composition of the integrated sequence as well as its DNA methylation status in CHO cells that can be obtained simultaneously from the same sequencing run. A Cas9‐enrichment step during library preparation enables targeted and directional nanopore sequencing with up to 724× median on‐target coverage and up to 153 kb long reads. The data generated by nCats provides sensitive, detailed, and correct information on the transgene integration sites and the expression vector structure, which could only be partly produced by traditional Targeted Locus Amplification‐seq data. Moreover, with nCats the DNA methylation status can be analyzed from the same raw data without prior DNA amplification.

20 January 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MKMiriam Klausberger
Miriam Klausberger
Mark DuerkopMark Duerkop
Mark Duerkop
HHHelmuth Haslacher
Helmuth Haslacher
GKGordana Wozniak Knopp
Gordana Wozniak Knopp
MCMonika Cserjan-Puschmann
Monika Cserjan-Puschmann
RGReingard Grabherr
Reingard Grabherr
Antibody tests are essential tools to investigate humoral immunity following SARS-CoV-2 infection. While first-generation antibody tests have primarily provided qualitative results with low specificity, accurate seroprevalence studies and tracking of antibody levels over time require highly specific, sensitive and quantitative test setups. Here, we describe two quantitative ELISA antibody tests based on the SARS-CoV-2 spike receptor-binding domain and the nucleocapsid protein. Comparative expression in bacterial, insect, mammalian and plant-based platforms enabled the identification of new antigen designs with superior quality and high suitability as diagnostic reagents. Both tests scored excellently in clinical validations with multi-centric specificity and sensitivity cohorts and showed unprecedented correlation with SARS-CoV-2 neutralization titers. Orthogonal testing increased assay specificity to 99.8%, thereby enabling robust serodiagnosis in low-prevalence settings. The inclusion of a calibrator permits accurate quantitative monitoring of antibody concentrations in samples collected at different time points during the acute and convalescent phase of COVID-19.